The compound STL 427944, recently identified by transcriptomic network analysis, was shown to block FOXM1 activity in various cancer cells by relocating nuclear FOXM1 to the cytoplasm, followed by autophagosomal degradation [82]. This evidence concerns the gene FOXM1 and cancer.